Literature DB >> 23402991

Local control and sequelae in localised Ewing tumours of the spine: a French retrospective study.

Guillaume Vogin1, Sylvie Helfre, Christophe Glorion, Véronique Mosseri, Eric Mascard, Odile Oberlin, Nathalie Gaspar.   

Abstract

OBJECTIVES: To evaluate both local outcome and sequelae of non-metastatic spinal Ewing tumours (EWT). PATIENTS AND METHODS: A French cohort of patients ≤ 50years with localised spinal EWT treated between 1988 and 2009, was analysed in regard to tumour characteristics (e.g. volume, vertebral compartment, spinal cord compression, paraspinal soft tissue invasion), local treatment modalities (surgery (S) and margin quality, radiotherapy (RT) dose), response to treatment (e.g. histological response to neoadjuvant chemotherapy (CT)), tumour local control (LC) and sequelae.
RESULTS: Seventy-five patients treated in successive trials were evaluated for LC: SFOP-EW88 (n=14), SFOP-EW93 (n=17) and EuroEwing99 (n=44). Fifty-seven patients (79%) presented initial neurological compression and 69% had inaugural decompressive S. Local treatment modality was S+RT (n=50), RT alone (n=19) and S alone (n=6). Surgery was mainly intralesional (66%). Local recurrences had occurred in 19 patients (14 local, 5 loco-regional) with a median interval of 25 months (1-50). After a 7 year median follow-up (1-22 years), the 5-year LC, relapse-free survival (RFS) and overall survival (OS) reached 78.0% (95%CI: 62.6-84.6), 57.0% (95%CI: 45.2-68.9) and 70.0% (95%CI: 59.1-81.0), respectively. Vertebral compartment involved was the only prognostic factor (5-year LC rate 100% versus 71% for favourable and unfavourable compartment, p<0.03). Among 41 five-year survivors, we observed spinal curvature deformation (35%), growth retardation (28%), spinal reduction mobility (40%), spinal pain (25%) and neurological sequelae (32%) without any significant association with a particular local procedure.
CONCLUSION: RT is the backbone of a successful local treatment of spinal EWT. The place of S remains a pending question. Its actual benefit will likely evolve with new available RT techniques.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23402991     DOI: 10.1016/j.ejca.2012.12.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Patient-Reported Functional and Quality of Life Outcomes in a Large Cohort of Long-Term Survivors of Ewing Sarcoma.

Authors:  Bradley J Stish; Safia K Ahmed; Peter S Rose; Carola A Arndt; Nadia N Laack
Journal:  Pediatr Blood Cancer       Date:  2015-08-14       Impact factor: 3.167

2.  Impact of first-line treatment on outcomes of Ewing sarcoma of the spine.

Authors:  Jianjun Zhang; Yujing Huang; Jing Lu; Aina He; Yan Zhou; Haiyan Hu; Zan Shen; Yuanjue Sun; Yang Yao
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 3.  Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management.

Authors:  George Galyfos; Georgios A Karantzikos; Nikolaos Kavouras; Argiri Sianou; Konstantinos Palogos; Konstantinos Filis
Journal:  Indian J Surg       Date:  2015-11-13       Impact factor: 0.656

Review 4.  Systematic Review of En Bloc Resection in the Management of Ewing's Sarcoma of the Mobile Spine with Respect to Local Control and Disease-Free Survival.

Authors:  Mathew David Sewell; Kimberly-Anne Tan; Nasir A Quraishi; Corina Preda; Peter P Varga; Richard Williams
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience.

Authors:  Ummugul Uyeturk; Kaan Helvaci; Ayse Demirci; Ozlem Uysal Sonmez; Ibrahim Turker; Cigdem Usul Afsar; Burcin Budakoglu; Ulku Yalcintas Arslan; Omur Berna Oksuzoglu; Nurullah Zengin
Journal:  Contemp Oncol (Pozn)       Date:  2016-03-21

6.  Case Report: Primary Ewing Sarcoma of the Penis With Multiple Metastases.

Authors:  Chuanxi Zheng; Yong Zhou; Yi Luo; Hongying Zhang; Chongqi Tu; Li Min
Journal:  Front Pediatr       Date:  2021-01-07       Impact factor: 3.418

7.  Ewing sarcoma of the ileum with wide multiorgan metastases: A case report and review of literature.

Authors:  Ai-Wen Guo; Yi-Sha Liu; Hang Li; Yi Yuan; Si-Xun Li
Journal:  World J Gastrointest Oncol       Date:  2022-08-15

8.  The impact of local control timing in Ewing sarcoma.

Authors:  Samer Salah; Hadeel Halalsheh; Fawzi Abuhijla; Taleb Ismael; Sameer Yaser; Ahmad Shehadeh; Samer Abdelal; Iyad Sultan; Abdelatif Almousa; Ramiz Abu Hijlih
Journal:  Rep Pract Oncol Radiother       Date:  2020-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.